Added to YB: 2024-04-12
Pitch date: 2024-04-09
INSM [bullish]
Insmed Incorporated
+151.94%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
Market Cap
$12.5B
Pitch Price
$27.59
Price Target
N/A
Dividend
N/A
Sector
Biotechnology
Category
growth
Show full summary:
ClearBridge Small Cap Growth Strategy New Position: Insmed Incorporated
INSM: Biopharma focused on rare lung diseases. Approved product growing domestically & internationally w/ label expansion potential. Late-stage pipeline w/ blockbuster sales potential.
Read full article (1 min)